SOLAR biotechnology, founded in 2011, aims to simplify complex systems in healthcare using a multidisciplinary approach to develop microfluidic IVD devices. Our company is supported by the Technological Innovation Capital Support program of the Ministry of Science, Technology and Industry of Turkey. Located in the Technology Development Region of Dokuz Eylul University, the main vision of SOLAR is to apply the results of scientific studies to industry.
SOLAR biotechnology merged with Genoma Medical Technologies in 2014 to gain know-how on instrument for conventional scale liquid handling.
We are a part of the Tumor Biobank of Dokuz Eylul University
Certifications: ISO 9001:2000 (oh-hold due to merge)
Kılıç Y, Çelebiler AÇ, Sakızlı M. Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer. Clinical and Translational Oncology 2013, DOI 10.1007/s12094-013-1058-5.
Celebiler CA, Sevinc A, Saydam S, Kılıç Y, et al. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue. Neoplasma 2010; 57(5):465-72.
Celebiler CA, Kılıç Y, Saydam S, Canda T, et al. Predicting Invasive Phenotype with CDH1, CDH13, CD44 and TIMP3 Gene Expressions in Primary Breast Cancer. Cancer Science 2009;100(12):2341-5.
Celebiler CA, Saydam S, Alakavuklar M, Kılıç Y, et al. A pilot study for human tumor/DNA banking: returned more questions than answers. Medical Oncology 2008;25(4):471-3.
Celebiler CA, Kılıç Y, Saydam S, Canda T, et al. Correlation of clinical data and expression levels of six tumor supressor genes in breast cancer. Cancer Research 2008;69(2):Supplement 1/1058.
SolarBiotec has not received any reviews.
SolarBiotec has not received any endorsements.